DiaMedica Therapeutics (DMAC) Other Gross PP&E Adjustments (2017 - 2026)
DiaMedica Therapeutics filings provide 10 years of Other Gross PP&E Adjustments readings, the most recent being $62000.0 for Q1 2026.
- Quarterly Other Gross PP&E Adjustments rose 188.57% to $62000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $62000.0 through Mar 2026, up 188.57% year-over-year, with the annual reading at -$22000.0 for FY2025, 82.95% up from the prior year.
- Other Gross PP&E Adjustments hit $62000.0 in Q1 2026 for DiaMedica Therapeutics, up from -$22000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $110000.0 in Q1 2022 and bottomed at -$305000.0 in Q2 2022.
- Average Other Gross PP&E Adjustments over 5 years is -$107352.9, with a median of -$98000.0 recorded in 2024.
- Peak annual rise in Other Gross PP&E Adjustments hit 197.3% in 2022, while the deepest fall reached 654.55% in 2022.
- DiaMedica Therapeutics' Other Gross PP&E Adjustments stood at -$208000.0 in 2022, then decreased by 6.25% to -$221000.0 in 2023, then soared by 41.63% to -$129000.0 in 2024, then soared by 82.95% to -$22000.0 in 2025, then surged by 381.82% to $62000.0 in 2026.
- Per Business Quant, the three most recent readings for DMAC's Other Gross PP&E Adjustments are $62000.0 (Q1 2026), -$22000.0 (Q4 2025), and -$26000.0 (Q3 2025).